{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:19Z","timestamp":1772119999645,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prophylactic endoscopic band ligation (EBL) is used to prevent variceal bleeding in patients with liver cirrhosis. The association of thrombocytopenia, high INR (international normalized ratio) and liver dysfunction with the risk of procedure-related bleeding (PRB) remains debated and recommendations are controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed real-life data of cirrhotic patients undergoing elective EBL at two large\u00a0Viennese centers between Q1\/2000\u2013Q1\/2018. PRB was defined as bleeding occurring within 30\u00a0days after EBL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 617 patients undergoing a total of 1178 prophylactic EBL procedures (median 2 per patient). Sixteen (2.6%) of 617 patients experienced PRB after a median of 12.5 (IQR 17.3) days with no difference in characteristics and laboratory values between the two groups. The proportion of patients with platelets (PLT)\u2009&lt;\u200950 G\/L or INR\u2009\u2265\u20091.5 was similar in patients with vs. without PRB. A higher MELD showed a non-significant association with EBL-related bleeding risk (odds ratio, OR 1.07; 95% confidence interval 95% CI 1.00\u20131.16, p\u2009=\u20090.058). While serum\u00a0bilirubin was a significant predictor for PRB (OR: 1.10; 95% CI 1.03\u20131.18), the presence of large varices (OR 0.85 vs. small varices; 95% CI 0.20\u20133.84), INR (OR 0.50; 95% CI 0.10\u20133.14), PLT (OR 1.00; 95% CI 1.00\u20131.01) and the use of non-selective betablockers (OR 1.20; CI 95% 0.38\u20133.76) were not associated with PRB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EBL is safe and procedure-related bleedings are rare (2.6%) including in patients with thrombocytopenia\u2009&lt;\u200950 G\/L or high INR\u2009\u2265\u20091.5. Only high MELD, and especially high bilirubin seem to be linked to an\u00a0increased risk of\u00a0EBL-related bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-023-10515-y","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T13:02:42Z","timestamp":1680786162000},"page":"1205-1214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Endoscopic band ligation is safe despite low platelet count and high INR"],"prefix":"10.1007","volume":"17","author":[{"given":"Nikolaus","family":"Pfisterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Jachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Putre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Ritt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Madl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-3583","authenticated-orcid":false,"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"10515_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","volume":"146","author":"E Reverter","year":"2014","unstructured":"Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412\u201319.e3","journal-title":"Gastroenterology"},{"key":"10515_CR2","doi-asserted-by":"publisher","unstructured":"Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969\u20132002. Hepatology [Internet]. 2006 ;43:500\u20135. http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/hep.21089. Cited 14 Jan 2020","DOI":"10.1002\/hep.21089"},{"key":"10515_CR3","doi-asserted-by":"crossref","unstructured":"Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, et al. Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis [Internet]. 2014;46:419\u201326. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865813006981. Cited 6 Nov 2017","DOI":"10.1016\/j.dld.2013.12.010"},{"key":"10515_CR4","doi-asserted-by":"publisher","unstructured":"D\u2019Amico G, de Franchis R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology [Internet]. 2003 ;38:599\u2013612. http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1053\/jhep.2003.50385. Cited 6 Nov 2017","DOI":"10.1053\/jhep.2003.50385"},{"key":"10515_CR5","doi-asserted-by":"crossref","unstructured":"Cerqueira RM, Andrade L, Correia MR, Fernandes CD, Manso MC. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol [Internet]. 2012;24:551\u20137. http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00042737-201205000-00013. Cited 14 Jan 2020","DOI":"10.1097\/MEG.0b013e3283510448"},{"key":"10515_CR6","unstructured":"de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol [Internet]. 2015;63:743\u201352. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815003499. Cited 6 Nov 2017"},{"key":"10515_CR7","doi-asserted-by":"publisher","unstructured":"Reiberger T, P\u00fcsp\u00f6k A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth\u00a0III). Wien Klin Wochenschr [Internet]. 2017;129:135\u2013158. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00508-017-1262-3. Cited 6 Nov 2017","DOI":"10.1007\/s00508-017-1262-3"},{"key":"10515_CR8","doi-asserted-by":"crossref","unstructured":"Garcia\u2010Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology [Internet]. 2017;65:310\u2013335. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27786365. Cited 16 Feb 2020","DOI":"10.1002\/hep.28906"},{"key":"10515_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Abraldes JG, et al. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u2013974","journal-title":"J Hepatol"},{"key":"10515_CR10","doi-asserted-by":"crossref","unstructured":"Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol [Internet]. 2021;13:731\u2013746. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/34367495\/. Cited 16 Mar 2022","DOI":"10.4254\/wjh.v13.i7.731"},{"key":"10515_CR11","doi-asserted-by":"crossref","unstructured":"Sharma M, Singh S, Desai V, Shah VH, Kamath PS, Murad MH, et al. Comparison of therapies for primary prevention of esophageal variceal bleeding: a systematic review and network meta-analysis. Hepatology [Internet]. 2019;69:1657\u20131675. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30125369. Cited 3 Dec 2020","DOI":"10.1002\/hep.30220"},{"key":"10515_CR12","doi-asserted-by":"crossref","unstructured":"Pfisterer N, Dexheimer C, Fuchs E-M, Bucsics T, Schwabl P, Mandorfer M, et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther [Internet]. 2018;47:966\u2013979. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29388229. Cited 16 Jan 2020","DOI":"10.1111\/apt.14485"},{"key":"10515_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1665-2681(19)30934-2","volume":"11","author":"N Funakoshi","year":"2012","unstructured":"Funakoshi N, Duny Y, Valats JC, S\u00e9galas-Largey F, Flori N, Bismuth M, et al. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Ann Hepatol. 2012;11:369\u2013383","journal-title":"Ann Hepatol"},{"key":"10515_CR14","doi-asserted-by":"crossref","unstructured":"Li L, Yu C, Li Y. Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol [Internet]. 2011;25:147\u201355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21499579. Cited 3 Dec 2020","DOI":"10.1155\/2011\/346705"},{"key":"10515_CR15","doi-asserted-by":"crossref","unstructured":"Jachs M, Reiberger T. Prevention of variceal bleeding and rebleeding by nonselective beta-blockers: a tailored approach. Clin Liver Dis [Internet]. 2021;25:311\u2013326. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/33838852\/. Cited 16 Mar 2022","DOI":"10.1016\/j.cld.2021.01.004"},{"key":"10515_CR16","unstructured":"Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, et al. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut [Internet]. 2020;Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/33199442\/. Cited 10 Feb 2021"},{"key":"10515_CR17","doi-asserted-by":"crossref","unstructured":"Pfisterer N, Riedl F, Pachofszky T, Gschwantler M, K\u00f6nig K, Schuster B, et al. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding\u2014a national multicentre study. Liver Int [Internet]. 2019;39:290\u2013298. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30248224. Cited 2 Aug 2020","DOI":"10.1111\/liv.13971"},{"key":"10515_CR18","doi-asserted-by":"crossref","unstructured":"Baroncini D, Milandri GL, Borioni D, Piemontese A, Cennamo V, Billi P, et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy [Internet]. 1997 ;29:235\u2013240. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/9255524\/. Cited 13 Mar 2022","DOI":"10.1055\/s-2007-1004182"},{"key":"10515_CR19","doi-asserted-by":"crossref","unstructured":"Laine L, El-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med [Internet]. 1993;119:1\u20137. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/8498757\/. Cited 13 Mar 2022","DOI":"10.7326\/0003-4819-119-1-199307010-00001"},{"key":"10515_CR20","doi-asserted-by":"crossref","unstructured":"Polski JM, Brunt EM, Saeed ZA. Chronology of histological changes after band ligation of esophageal varices in humans. Endoscopy [Internet]. 2001;33:443\u2013447. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/11396765\/. Cited 7 Jul 2022","DOI":"10.1055\/s-2001-14259"},{"key":"10515_CR21","doi-asserted-by":"crossref","unstructured":"Lo G-H, Chen W-C, Wang H-M, Lee C-C. Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding. Hepatology [Internet]. 2010;52:230\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20578138. Cited 28 Jul 2020","DOI":"10.1002\/hep.23617"},{"key":"10515_CR22","doi-asserted-by":"crossref","unstructured":"Sinclair M, Vaughan R, Angus PW, Gow PJ, Parker F, Hey P, et al. Risk factors for band-induced ulcer bleeding after prophylactic and therapeutic endoscopic variceal band ligation. Eur J Gastroenterol Hepatol [Internet]. 2015;27:928\u201332. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25951490. Cited 27 Jul 2020","DOI":"10.1097\/MEG.0000000000000387"},{"key":"10515_CR23","unstructured":"Drolz A, Schramm C, Seiz O, Groth S, Vettorazzi E, Horvatits T, et al. Risk factors associated with bleeding after prophylactic endoscopic variceal ligation in cirrhosis. Endoscopy [Internet]. 2020: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32894867. Cited 18 Sep 2020"},{"key":"10515_CR24","doi-asserted-by":"crossref","unstructured":"Sarin SK, Govil A, Jain AK, Guptan RC, Issar SK, Jain M, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence. J Hepatol [Internet]. 1997 ;26:826\u2013832. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/9126795\/. Cited 20 Jan 2021","DOI":"10.1016\/S0168-8278(97)80248-6"},{"key":"10515_CR25","doi-asserted-by":"crossref","unstructured":"Stiegmann G v., Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic Sclerotherapy as Compared with Endoscopic Ligation for Bleeding Esophageal Varices. New England Journal of Medicine [Internet]. 1992;326:1527\u20131532. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/1579136\/. Cited 20 Jan 2021","DOI":"10.1056\/NEJM199206043262304"},{"key":"10515_CR26","doi-asserted-by":"crossref","unstructured":"Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc [Internet]. 2004;59:333\u2013338. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/14997127\/. Cited 16 Mar 2022","DOI":"10.1016\/S0016-5107(03)02819-0"},{"key":"10515_CR27","doi-asserted-by":"crossref","unstructured":"Xu L, Ji F, Xu QW, Zhang MQ. Risk factors for predicting early variceal rebleeding after endoscopic variceal ligation. World J Gastroenterol [Internet]. 2011;17:3347\u20133352. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/21876624\/. Cited 16 Mar 2022","DOI":"10.3748\/wjg.v17.i28.3347"},{"key":"10515_CR28","doi-asserted-by":"crossref","unstructured":"Vanbiervliet G, Giudicelli-Bornard S, Piche T, Berthier F, Gelsi E, Filippi J, et al. Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment Pharmacol Ther [Internet]. 2010 32:225\u2013232. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/20412065\/. Cited 7 Jul 2022","DOI":"10.1111\/j.1365-2036.2010.04331.x"},{"key":"10515_CR29","doi-asserted-by":"crossref","unstructured":"Tierney A, Toriz BE, Mian S, Brown KE. Interventions and outcomes of treatment of postbanding ulcer hemorrhage after endoscopic band ligation: a single-center case series. Gastrointest Endosc [Internet]. 2013;77. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/23062759\/. Cited 7 Jul 2022","DOI":"10.1016\/j.gie.2012.08.031"},{"key":"10515_CR30","doi-asserted-by":"crossref","unstructured":"Vieira da Rocha EC, D\u2019Amico EA, Caldwell SH, Flores da Rocha TR, Soares E Silva CSS, dos Santos Bomfim V, et al. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol [Internet]. 2009 ;7:988\u2013993. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/19410018\/. Cited 7 Jul 2022","DOI":"10.1016\/j.cgh.2009.04.019"},{"key":"10515_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.dld.2019.06.019","volume":"52","author":"E Due\u00f1as","year":"2020","unstructured":"Due\u00f1as E, Cachero A, Amador A, Rota R, Salord S, Gornals J, et al. Ulcer bleeding after band ligation of esophageal varices: risk factors and prognosis. Dig Liver Dis. 2020;52:79\u201383","journal-title":"Dig Liver Dis"},{"key":"10515_CR32","doi-asserted-by":"publisher","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology [Internet]. 2017;65:310\u2013335. http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/hep.28906.Cited 15 Jan 2018","DOI":"10.1002\/hep.28906.Cited"},{"key":"10515_CR33","doi-asserted-by":"crossref","unstructured":"Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl [Internet]. 2011;17 Suppl 2. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/21695773\/. Cited 16 Mar 2022","DOI":"10.1002\/lt.22365"},{"key":"10515_CR34","doi-asserted-by":"crossref","unstructured":"Tafarel JR, Tolentino LHL, Correa LM, Bonilha DR, Piauilino P, Martins FP, et al. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. Eur J Gastroenterol Hepatol [Internet]. 2011;23:754\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21691209. Cited 8 Dec 2020","DOI":"10.1097\/MEG.0b013e3283488a88"},{"key":"10515_CR35","doi-asserted-by":"crossref","unstructured":"Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology [Internet]. 1985;5:419\u201324. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3873388. Cited 3 Dec 2020","DOI":"10.1002\/hep.1840050313"},{"key":"10515_CR36","doi-asserted-by":"crossref","unstructured":"Wadhawan M, Dubey S, Sharma BC, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child\u2019s status. Dig Dis Sci [Internet]. 2006 ;51:2264\u20132269. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/17080245\/. Cited 15 Mar 2022","DOI":"10.1007\/s10620-006-9310-2"},{"key":"10515_CR37","doi-asserted-by":"crossref","unstructured":"Moitinho E, Escorsell A, Bandi JC, Salmer\u00f3n JM, Garc\u00eda-Pag\u00e1n JC, Rod\u00e9s J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology [Internet]. 1999;117:626\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10464138. Cited 7 Dec 2020","DOI":"10.1016\/S0016-5085(99)70455-5"},{"key":"10515_CR38","doi-asserted-by":"crossref","unstructured":"Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices\u2014a prospective controlled randomized trial. Endoscopy [Internet]. 1982;14:4\u20135. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/7035153\/. Cited 15 Mar 2022","DOI":"10.1055\/s-2007-1021560"},{"key":"10515_CR39","doi-asserted-by":"crossref","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, Garcia-Pagan JC, Calleja JL, Aracil C, et al. \u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet [Internet]. 2019;393:1597\u20131608. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/30910320\/. Cited 15 Jan 2021","DOI":"10.1016\/S0140-6736(18)31875-0"},{"key":"10515_CR40","doi-asserted-by":"crossref","unstructured":"Reiberger T. The value of liver and spleen stiffness for evaluation of portal hypertension in compensated cirrhosis. Hepatol Commun [Internet]. 2022;6:950\u2013964. https:\/\/pubmed.ncbi.nlm.nih.gov\/34904404\/. Cited 17 Oct 2022","DOI":"10.1002\/hep4.1855"},{"key":"10515_CR41","unstructured":"Pfisterer N, Schmidbauer C, Riedl F, Maieron A, Stadlbauer V, Hennlich B, et al. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria. Wien Klin Wochenschr [Internet]. 2020 https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/33270161\/. Cited 4 Jan 2021"},{"key":"10515_CR42","doi-asserted-by":"crossref","unstructured":"Li Y, Guo X, Bai Z, Shao X, Wang R, Li H, et al. Banana may be forbidden after endoscopic variceal ligation: a case report. Transl Gastroenterol Hepatol [Internet]. 2019;4. https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/30976716\/. Cited 16 Mar 2022","DOI":"10.21037\/tgh.2019.01.11"},{"key":"10515_CR43","doi-asserted-by":"crossref","unstructured":"Hou MC. Is there adequate evidence to encourage early feeding in patients with acute esophageal variceal bleeding? J Chin Med Assoc [Internet]. 2015;78:631\u2013632. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/26360242\/. Cited 16 Mar 2022","DOI":"10.1016\/j.jcma.2015.07.006"},{"key":"10515_CR44","doi-asserted-by":"crossref","unstructured":"Lo GH, Lin CW, Hsu YC. A controlled trial of early versus delayed feeding following ligation in the control of acute esophageal variceal bleeding. J Chin Med Assoc [Internet]. 2015;78:642\u2013647. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ez.srv.meduniwien.ac.at\/26341455\/. Cited 16 Mar 2022","DOI":"10.1016\/j.jcma.2015.07.004"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10515-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T02:21:55Z","timestamp":1703298115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10515-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10515"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10515-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2316965\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"27 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N. Pfisterer\u00a0received travel support from Abbvie and MSD. Mattias\u00a0Mandorfer has served as a speaker and\/or consultant and\/or advisory board member for AbbVie, Bristol\u2010Myers Squibb, Gilead, Janssen and W. L. Gore & Associates and has received a research award from Medis.\nThomas\u00a0Reiberger received travel support from Boehringer\u2010Ingelheim, WL Gore, Gilead, Roche and MSD; grant support from Abbvie, Boehringer\u2010Ingelheim, Gilead, WL Gore, Phenex Pharmaceuticals and Philipps; served on advisory boards for Abbvie, Bayer, Boehringer\u2010Ingelheim, Gilead and MSD; and received lecture fees from Boehringer\u2010Ingelheim, Gore, MSD and Roche. Michael\u00a0Trauner received travel support from Abbvie, Falk, Gilead, and Intercept and Jannsen; research grants from Albireo, Alnylam, Cymabay, Falk, Gilead, Intercept, MSD and Takeda and Ultagenyx; advisory board fees from Abbvie, Albireo, BiomX, Boehringer Ingelheim, Falk, Genfit, Gilead, Hightide, Intercept, Janssen, MSD, Novartis, Phenex, Pliant, Regulus, Siemens and Shire; lecture fees from BMS, Falk, Gilead, Intercept, and MSD and Roche; he is co-inventor of patents on the medical use of norUDCA filed by the Medical University of Graz. The other authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the Medical University of Vienna (EK#1666\/2015) and the ethics committee of the Wiener Gesundheitsverbund in Vienna (MA-15, EK#15-280-VK).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}